Nektar reported a net loss for the quarter ended September 30, 2008 of $37.0 million or $0.40 per share, compared to a net loss of $18.6 million or $0.20 per share in the third quarter of 2007. For the first nine months of 2008, the company reported a net loss of $111.1 million or $1.20 per share, compared to a net loss of $71.8 million or $0.78 per share for the same period in 2007.
Conference Call to Discuss Third Quarter 2008 Financial Results
Nektar will host a conference call today for analysts and investors at
2:00 p.m. Pacific time to discuss the company's third quarter performance.
This conference call will be available via webcast and can be accessed
through a link that is posted on the Investor Relations section of the
Nektar website, http://www.nektar.com. The web broadcast of the conference
call will be available for replay through November 20, 2008.
To access the conference call, follow these instructions:
Dial: 866-362-4666 (U.S.); 617-597-5313 (international)
Participant Passcode: 63756947 (Howard Robin is the host)
Audio replay dial-in and passcode:
To access the replay, follow these instructions:
Dial: 888-286-8010 (U.S.); 617-801-6888 (international)
Participant Passcode: 41304675
Nektar to Host Annual R&D Day on November 12
Nektar will host its second annual R&D Day meeting on Wednesday,
November 12, 2008 from 12:00 pm to 3:30 pm Eastern time at the
InterContinental Hotel in New York City. For more information or to RSVP
for this event, please visit the investor relations section of the
company's website at http://www.nek
|SOURCE Nektar Therapeutics|
Copyright©2008 PR Newswire.
All rights reserved